Literature DB >> 26499783

Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1.

Kewei Zhu1, Wanchun Wang2.   

Abstract

(-)-Epigallocatechin-3-gallate (EGCG), the most abundant and active polyphenol in green tea, has been demonstrated to have anticancer effects in a wide variety of human cancer. MicroRNAs (miRNAs) are a class of short noncoding RNAs and play important role in gene regulation and are critically involved in the pathogenesis and progression of human cancer. This study aims to investigate the effects of EGCG on osteosarcoma (OS) cells and elucidate the underlying mechanism. Cellular function assays revealed that EGCG inhibited cell proliferation, induced cell cycle arrest and promoted apoptosis of OS cells in vitro, and also inhibited the growth of transplanted tumors in vivo. By miRNA microarray and RT-qPCR analysis, miR-1 was found to be significantly upregulated in MG-63 and U-2OS treated by EGCG in dose- and time-dependent manners, and miR-1 downregulation by inhibitor mimics attenuated EGCG-induced inhibition on cell growth of OS cells. We also confirmed that miR-1 was also frequently decreased in clinical OS tumor tissues. Moreover, both EGCG and miR-1 mimic inhibited c-MET expression, and combination treatment with EGCG and c-MET inhibitor (crizotinib) had enhanced inhibitory effects on the growth of MG-63 and U-2OS cells. Taken together, these results suggest that EGCG has an anticancer effect on OS cells, at least partially, through regulating miR-1/c-MET interaction.

Entities:  

Keywords:  (−)-Epigallocatechin-3-gallate (EGCG); Crizotinib; MicroRNA-1; Osteosarcoma; c-MET

Mesh:

Substances:

Year:  2015        PMID: 26499783     DOI: 10.1007/s13277-015-4187-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  32 in total

Review 1.  Regulating miRNA by natural agents as a new strategy for cancer treatment.

Authors:  Sajiv Sethi; Yiwei Li; Fazlul H Sarkar
Journal:  Curr Drug Targets       Date:  2013-09       Impact factor: 3.465

2.  The functional significance of miR-1 and miR-133a in renal cell carcinoma.

Authors:  Kazumori Kawakami; Hideki Enokida; Takeshi Chiyomaru; Shuichi Tatarano; Hirofumi Yoshino; Ichiro Kagara; Takenari Gotanda; Tokushi Tachiwada; Kenryu Nishiyama; Nijiro Nohata; Naohiko Seki; Masayuki Nakagawa
Journal:  Eur J Cancer       Date:  2012-04       Impact factor: 9.162

3.  Going Green: The Role of the Green Tea Component EGCG in Chemoprevention.

Authors:  Laura Schramm
Journal:  J Carcinog Mutagen       Date:  2013-05-20

4.  MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer.

Authors:  Cristina Migliore; Valentina Martin; Vera P Leoni; Angelo Restivo; Luigi Atzori; Annalisa Petrelli; Claudio Isella; Luigi Zorcolo; Ivana Sarotto; Giuseppe Casula; Paolo M Comoglio; Amedeo Columbano; Silvia Giordano
Journal:  Clin Cancer Res       Date:  2011-12-16       Impact factor: 12.531

5.  MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1.

Authors:  Dong Li; Pengyuan Yang; Hua Li; Peng Cheng; Ling Zhang; Dong Wei; Xiaomei Su; Jingjing Peng; Hui Gao; Yong Tan; Zhenguo Zhao; Yan Li; Zhongchun Qi; Yaocheng Rui; Tao Zhang
Journal:  Life Sci       Date:  2012-08-20       Impact factor: 5.037

6.  A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer.

Authors:  Dominique Trudel; David P Labbé; Monica Araya-Farias; Alain Doyen; Laurent Bazinet; Thierry Duchesne; Marie Plante; Jean Grégoire; Marie-Claude Renaud; Dimcho Bachvarov; Bernard Têtu; Isabelle Bairati
Journal:  Gynecol Oncol       Date:  2013-08-27       Impact factor: 5.482

Review 7.  miRNA as molecular target of polyphenols underlying their biological effects.

Authors:  Dragan Milenkovic; Baptiste Jude; Christine Morand
Journal:  Free Radic Biol Med       Date:  2013-06-07       Impact factor: 7.376

Review 8.  miRNAs in human cancer.

Authors:  Thalia A Farazi; Jessica I Spitzer; Pavel Morozov; Thomas Tuschl
Journal:  J Pathol       Date:  2010-11-18       Impact factor: 7.996

9.  The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.

Authors:  H Yoshino; T Chiyomaru; H Enokida; K Kawakami; S Tatarano; K Nishiyama; N Nohata; N Seki; M Nakagawa
Journal:  Br J Cancer       Date:  2011-02-08       Impact factor: 7.640

10.  MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer.

Authors:  Robert S Hudson; Ming Yi; Dominic Esposito; Stephanie K Watkins; Arthur A Hurwitz; Harris G Yfantis; Dong H Lee; James F Borin; Michael J Naslund; Richard B Alexander; Tiffany H Dorsey; Robert M Stephens; Carlo M Croce; Stefan Ambs
Journal:  Nucleic Acids Res       Date:  2011-12-30       Impact factor: 16.971

View more
  20 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Epigallocatechin-3-O-gallate modulates global microRNA expression in interleukin-1β-stimulated human osteoarthritis chondrocytes: potential role of EGCG on negative co-regulation of microRNA-140-3p and ADAMTS5.

Authors:  Zafar Rasheed; Naila Rasheed; Osama Al-Shaya
Journal:  Eur J Nutr       Date:  2017-01-21       Impact factor: 5.614

Review 3.  How Diet Intervention via Modulation of DNA Damage Response through MicroRNAs May Have an Effect on Cancer Prevention and Aging, an in Silico Study.

Authors:  Felicia Carotenuto; Maria C Albertini; Dario Coletti; Alessandra Vilmercati; Luigi Campanella; Zbigniew Darzynkiewicz; Laura Teodori
Journal:  Int J Mol Sci       Date:  2016-05-19       Impact factor: 5.923

4.  miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells.

Authors:  Junjie Niu; Yibao Sun; Qiaoge Guo; Dongju Niu; Bo Liu
Journal:  Dis Markers       Date:  2016-09-29       Impact factor: 3.434

5.  Abnormal alterations of miR-1 and miR-214 are associated with clinicopathological features and prognosis of patients with PDAC.

Authors:  Qing Cheng; Li-Hua Han; Hai-Juan Zhao; Hui Li; Jian-Bing Li
Journal:  Oncol Lett       Date:  2017-08-24       Impact factor: 2.967

6.  Formulation and characterization of EGCG for the treatment of superficial bladder cancer.

Authors:  Katarzyna Dettlaff; Maciej Stawny; Magdalena Ogrodowczyk; Anna Jelińska; Waldemar Bednarski; Dorota Wątróbska-Świetlikowska; Rick W Keck; Omar A Khan; Ibrahim H Mostafa; Jerzy Jankun
Journal:  Int J Mol Med       Date:  2017-06-14       Impact factor: 4.101

Review 7.  Dietary Intervention by Phytochemicals and Their Role in Modulating Coding and Non-Coding Genes in Cancer.

Authors:  Liviuta Budisan; Diana Gulei; Oana Mihaela Zanoaga; Alexandra Iulia Irimie; Chira Sergiu; Cornelia Braicu; Claudia Diana Gherman; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2017-06-01       Impact factor: 5.923

Review 8.  MicroRNA-1: Diverse role of a small player in multiple cancers.

Authors:  Parvez Khan; Nivetha Sarah Ebenezer; Jawed Akhtar Siddiqui; Shailendra Kumar Maurya; Imayavaramban Lakshmanan; Ravi Salgia; Surinder Kumar Batra; Mohd Wasim Nasser
Journal:  Semin Cell Dev Biol       Date:  2021-05-24       Impact factor: 7.727

9.  EGCG Suppresses ERK5 Activation to Reverse Tobacco Smoke-Triggered Gastric Epithelial-Mesenchymal Transition in BALB/c Mice.

Authors:  Ling Lu; Jia Chen; Hua Tang; Ling Bai; Chun Lu; Kehuan Wang; Manli Li; Yinmei Yan; Ling Tang; Rui Wu; Yang Ye; Longtao Jin; Zhaofeng Liang
Journal:  Nutrients       Date:  2016-07-20       Impact factor: 5.717

10.  Epigallocatechin-3-O-gallate up-regulates microRNA-199a-3p expression by down-regulating the expression of cyclooxygenase-2 in stimulated human osteoarthritis chondrocytes.

Authors:  Zafar Rasheed; Naila Rasheed; Hani A Al-Shobaili
Journal:  J Cell Mol Med       Date:  2016-08-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.